studi
investig
virus
bovin
respiratori
diseas
brd
case
feedlot
includ
bovin
bovin
viral
diarrhea
viru
bvdv
bovin
respiratori
syncyti
viru
brsv
bovin
coronavirus
bocv
viru
nasal
swab
collect
cattl
initi
brd
treatment
process
includ
modifi
live
viru
mlv
vaccin
seven
brd
necropsi
case
includ
total
case
mean
number
day
feed
first
sampl
day
swab
tissu
homogen
test
gel
base
pcr
gpcr
quantitativepcr
qpcr
quantit
real
time
revers
transcriptas
pcr
qrtpcr
viral
cultur
swab
posit
least
one
viru
least
one
test
necropsi
case
posit
least
one
viru
case
posit
includ
bvdv
bocv
brsv
nasal
swab
gpcr
virus
detect
qpcr
qrtpcr
virus
detect
viru
isol
detect
posit
one
two
test
three
test
necropsi
case
posit
gpcr
qpcr
qrtpcr
posit
cell
cultur
case
gpcr
real
time
pcr
neg
bvdv
sampl
posit
cultur
pcr
differenti
field
vaccin
strain
bvdv
howev
base
sequenc
analysi
field
vaccin
strain
cultur
posit
bocv
bvdv
isol
bvdv
isol
identifi
vaccin
brsv
identifi
pcr
test
interpret
laboratori
test
appropri
molecular
base
test
viru
isol
separ
field
vaccin
strain
addit
test
use
sequenc
appear
appropri
identifi
vaccin
strain
bovin
respiratori
diseas
brd
associ
infect
complic
stress
addit
bacteria
includ
mannheimia
haemolytica
pasteurella
multocida
histophilu
somni
mycoplasma
spp
brd
etiolog
includ
bovin
bovin
viral
diarrhea
virus
bvdv
bovin
respiratori
syncyti
viru
brsv
viru
bovin
depend
test
avail
sever
studi
use
sampl
collect
necropsi
test
sever
virus
varieti
test
list
studi
test
multipl
virus
respiratori
materi
affect
cattl
ant
mortem
swab
includ
follow
list
mani
year
tradit
test
cultur
assay
use
identifi
virus
howev
modern
test
molecular
test
becom
commonplac
histor
mainstay
virolog
workup
brd
case
combin
immunofluoresc
attempt
viral
isol
past
two
decad
molecular
assay
increasingli
supplant
classic
method
strength
weak
tradit
molecular
test
interpret
report
issu
face
clinician
includ
interpret
posit
test
anim
brd
sign
prior
mlv
vaccin
discret
exercis
interpret
laboratori
test
recent
mlv
vaccin
cattl
brd
identifi
viru
posit
nucleic
acid
repres
virul
field
infect
mlv
strain
studi
purpos
three
fold
test
nasal
swab
cattl
treat
brd
receiv
mlv
vaccin
necropsi
tissu
vari
test
includ
cultur
molecular
test
test
cultur
posit
determin
specif
type
subgenotyp
clade
viral
sequenc
determin
specif
virus
field
mlv
strain
group
includ
sampl
submit
fall
repres
sampl
collect
period
time
deliv
test
group
nasal
swab
collect
cattl
pull
initi
brd
treatment
sampl
includ
seven
anim
die
group
cattl
receiv
mlv
vaccin
entri
vaccin
use
list
tabl
tabl
rectal
temperatur
collect
record
inform
group
day
feed
dof
collect
vaccin
similar
inform
record
necropsi
case
tabl
sampl
submit
depart
veterinari
pathobiolog
oklahoma
state
univers
stillwat
ok
test
virus
cattl
receiv
mlv
vaccin
contain
predomin
howev
limit
number
receiv
brsv
nasal
swab
tissu
homogen
sent
athen
veterinari
diagnost
laboratori
univers
georgia
athen
ga
viru
isol
perform
modifi
inoculum
adsorb
onto
onedayold
monolay
madin
darbi
bovin
kidney
mdbk
cell
plate
h
c
medium
contain
fetal
bovin
serum
ad
monolay
incub
c
plate
examin
cytopath
effect
cpe
day
cell
trypsin
test
noncytopath
ncp
bvdv
direct
fluoresc
antibodi
techniqu
dfat
cpe
observ
remain
cell
trypsin
transfer
onto
spot
slide
stain
dfat
use
commerci
fluorescein
isothiocyanateconjug
antibodi
bvdv
brsv
bovin
veterinari
medic
research
develop
pullman
wa
cultur
show
cpe
frozen
clarifi
centrifug
g
supernat
save
viru
isol
cpe
observ
cell
subcultur
trypsin
second
passag
test
bvdv
report
neg
also
inoculum
test
oklahoma
state
univers
mdbk
observ
cpe
test
bvdv
gelbas
pcr
gpcr
inoculum
test
bocv
use
human
rectal
tumor
cell
monolay
cultur
observ
day
cultur
regardless
presenceabs
cpe
test
gpcr
initi
hrt
monolay
passag
use
studi
nasal
swab
tissu
homogen
test
nucleic
acid
product
gpcr
test
bovin
virus
viral
nucleic
acid
swab
homogen
process
describ
gpcr
amplifi
fragment
gene
pcr
product
brsv
gpcr
f
protein
region
bocv
assay
detect
region
n
gene
bvdv
primer
design
gene
detect
distinguish
subgenotyp
gpcr
primer
detect
region
f
gene
quantit
real
time
pcr
test
qpcr
dna
viru
quantit
revers
transcriptas
pcr
qrtpcr
rna
virus
perform
anim
diseas
research
diagnost
laboratorydepart
veterinari
biomed
scienc
south
dakota
state
univers
brook
sd
viral
nucleic
acid
collect
describ
qrtpcr
qpcr
detect
two
virus
simultan
bvdv
brsv
bocv
ct
valu
consid
posit
suspect
neg
ct
detect
ct
valu
bvdv
rtpcr
primer
target
utr
primer
detect
region
thymidin
kinas
tk
rtpcr
brsv
detect
conserv
n
gene
region
bocv
rtpcr
detect
amplifi
protein
region
encod
orf
viral
sequenc
bvdv
bocv
perform
us
depart
agricultur
servic
nation
anim
diseas
center
ame
ia
bvdv
genotyp
base
comparison
utr
refer
strain
strain
commerci
avail
bvdv
vaccin
north
america
cp
strain
mlv
bvdv
vaccin
includ
cultur
isol
analyz
whole
genom
sequenc
singl
nucleotid
polymorph
sequenc
pcr
product
use
differ
pcr
primer
test
identifi
vaccin
strain
distinguish
field
strain
test
use
near
complet
genom
sequenc
total
necropsi
phylogenet
analysi
us
vaccin
strain
contain
genotyp
phylogenet
analysi
bocv
sequenc
base
section
gene
protein
gene
bocv
clade
us
includ
comparison
made
use
conting
tabl
chi
squar
test
compar
proport
yield
signific
result
pair
proport
conting
tabl
signific
express
p
vax
contain
mlv
virus
brsv
wherea
vax
contain
three
group
anim
dof
sampl
collect
tabl
two
anim
dof
exclud
two
dof
rang
group
anim
dof
tabl
group
anim
dof
tabl
necropsi
case
dof
tabl
studi
remov
two
anim
day
dof
dof
remaind
anim
rang
mean
day
feed
initi
collect
day
relationship
test
one
anoth
examin
sampl
nasal
swab
necropsi
case
numer
case
anim
may
posit
one
test
two
test
specif
pathogen
neg
one
two
test
total
posit
qpcr
posit
cultur
qpcr
posit
qpcr
posit
gpcr
cultur
posit
qpcr
neg
anim
posit
three
test
bvdv
posit
qrtpcr
cultur
posit
posit
gpcr
qrtpcr
posit
case
posit
three
bvdv
test
one
anim
suspect
qrtpcr
posit
gpcr
two
qrtpcr
suspect
cultur
posit
posit
bocv
qrtpcr
test
cultur
posit
qrtpct
bocv
posit
gpcr
posit
two
case
qrtpcr
neg
bocv
two
cultur
posit
case
posit
three
bocv
test
one
case
gpcr
posit
suspect
qrtpcr
two
cultur
posit
bocv
rtpcr
suspect
cultur
posit
brsv
brsv
posit
qrtpcr
posit
gpcr
sampl
cultur
posit
one
posit
gpcr
viru
cultur
posit
submit
genet
analysi
determin
specif
type
subgenotyp
clade
compar
vaccin
strain
tabl
sampl
cultur
posit
mlv
vaccin
strain
field
strain
vaccin
sampl
posit
bvdv
mlv
vaccin
strain
vaccin
field
strain
two
could
classifi
bvdv
field
strain
includ
ncp
strain
three
ncp
strain
unrel
vaccin
two
bvdv
strain
necropsi
group
could
identifi
one
band
pcr
step
sequenc
second
two
band
pcr
unabl
sequenc
bvdv
virus
place
respect
vaccin
greater
homolog
respect
vaccin
strain
cultur
posit
bocv
strain
limit
number
sequenc
bocv
clade
statu
cultur
posit
nasal
swab
sequenc
group
group
bocv
clade
cultur
posit
brsv
cultur
posit
one
calf
group
result
isol
vaccin
calf
receiv
mlv
vaccin
contain
remain
cultur
posit
three
b
six
c
indic
field
strain
whenev
vaccin
strain
identifi
case
almost
case
virus
vaccin
strain
receiv
process
except
group
two
anim
receiv
vax
process
howev
strain
identifi
nasal
swab
ident
strain
vax
vax
necropsi
case
anim
receiv
vax
process
howev
identifi
ident
strain
vax
vax
addit
calf
bvdv
strain
isol
nadl
cp
strain
found
vax
vax
yet
vax
mlv
vaccin
contain
singer
strain
thu
isol
appear
vaccin
given
prior
process
inform
avail
vaccin
statu
prior
entri
inform
vaccin
administ
cattl
adjac
pen
one
necropsi
case
tabl
gross
microscop
lesion
trachea
compat
form
ibr
field
strain
isol
howev
one
necropsi
case
tabl
gross
lesion
tracheiti
fresh
tissu
submit
vaccin
strain
isol
relat
mlv
vaccin
given
process
dof
process
sampl
nasal
swab
necropsi
tissu
collect
recoveri
vaccin
field
strain
virus
vaccin
strain
day
field
strain
day
bvdv
vaccin
strain
day
field
strain
day
vaccin
strain
day
field
strain
day
bocv
vaccin
report
studi
bocv
dof
durat
process
till
sampl
collect
day
day
dof
durat
process
brsv
posit
day
studi
provid
new
data
respiratori
infect
cattl
base
varieti
sever
pathogen
test
multipl
virus
recov
use
differ
test
nasal
swab
cattl
pull
initi
brd
treatment
receiv
mlv
vaccin
brd
necropsi
case
three
differ
test
evalu
virus
includ
gpcr
qpcr
qrtpcr
cultur
monolay
genom
test
perform
virus
recov
cultur
identifi
viru
type
subgenotyp
clade
determin
recov
virus
vaccin
field
strain
studi
expand
knowledg
virus
associ
brd
addit
character
virus
better
identifi
virus
genotyp
vaccin
origin
studi
use
viru
isol
fluoresc
antibodi
immunohistochemistri
viral
cultur
bovin
sampl
collect
respiratori
tract
necropsi
tissuesswab
studi
gave
excel
inform
etiolog
agent
found
materi
howev
test
use
discrimin
field
versu
vaccin
strain
mani
laboratori
access
molecular
sequenc
nucleic
acid
analysi
possibl
virus
could
identifi
complet
viral
isol
nucleic
acid
tissu
use
multipl
test
detect
virus
result
diverg
result
exampl
sampl
posit
bocv
three
test
viral
cultur
gpcr
qrtpcr
posit
three
test
bvdv
numer
case
sampl
posit
one
two
test
neg
potenti
factor
differ
identif
includ
pcr
test
detect
viral
nucleic
acid
infecti
viru
viral
cultur
requir
infecti
viru
pcr
addit
factor
might
includ
individu
laboratori
test
interpret
test
result
studi
three
differ
laboratori
perform
three
test
studi
use
sampl
clinic
ill
cattl
submit
test
virus
identifi
nasal
swab
cattl
pull
brd
treatment
feedlot
virus
found
frequent
initi
phase
brd
enter
cattl
even
mlv
vaccin
potenti
cattl
may
infect
prior
entri
arriv
regardless
clinician
manag
submit
sampl
diagnost
laboratori
receiv
result
must
interpret
result
determin
manag
measur
efficaci
modifi
question
whether
clinic
normal
cohort
anim
shed
virus
valid
address
current
studi
dealt
clinic
ill
cattl
recoveri
rate
viru
nasal
swab
indic
five
brd
virus
common
initi
stage
brd
feedlot
posit
bvdv
bocv
brsv
necropsi
case
posit
viru
bvdv
brsv
diagnost
laboratori
great
move
molecular
test
variou
pcr
test
usual
multiplex
less
emphasi
viru
isol
due
econom
factor
volum
sampl
test
autom
labor
speed
test
howev
clinician
seek
inform
etiolog
variou
clinic
form
thu
greater
use
molecular
test
multiplex
pcr
test
offer
consider
opportun
viru
identif
molecular
test
detect
infecti
viru
viral
nucleic
acid
realist
posit
test
result
give
indic
presenc
viru
especi
herd
basi
howev
shortcom
test
separ
vaccin
field
strain
immunohistochemistri
fluoresc
antibodi
necropsi
tissu
molecular
even
viral
cultur
posit
report
indic
etiolog
agent
without
distinct
field
vaccin
strain
design
recent
public
tradit
contemporari
test
equin
state
addit
pcr
test
import
perform
viru
isol
outbreak
diseas
archiv
strain
respect
molecular
character
molecular
epidemiolog
investig
practic
speak
diagnost
laboratori
evid
potenti
legal
action
regard
sourc
infect
save
tissu
posit
molecular
test
could
archiv
request
clinician
anim
owner
desir
separ
posit
vaccin
field
strain
refer
laboratori
genom
sequenc
capabl
might
use
test
although
like
cost
factor
regard
issu
gold
standard
respiratori
diseas
diagnosi
import
distinguish
infect
versu
diseas
report
look
question
ask
organ
identif
without
lesion
confirm
infect
organ
identif
plu
lesion
prove
diseas
may
clinic
subclin
organ
identif
plu
lesion
plu
clinic
sign
explain
diseas
prove
clinic
diseas
one
recommend
clinician
submit
sampl
live
anim
laboratori
result
posit
test
virus
respiratori
swab
peripher
blood
live
anim
evid
infect
herd
group
anim
repres
sampl
alert
clinician
infecti
agent
present
continu
monitor
includ
submiss
sampl
anim
die
diseas
especi
die
acut
diseas
clinic
sign
diverg
opinion
molecular
test
compar
tradit
cultur
center
definit
review
diagnost
test
balasuriya
et
al
detect
viru
cite
refer
state
viru
isol
cell
cultur
gold
standard
viru
isol
unequivoc
demonstr
presenc
infecti
viru
sampl
result
refer
gold
standard
laboratori
identif
infect
somewhat
diverg
view
express
discuss
viru
cultur
negativepcr
posit
result
felin
respiratori
infect
studi
author
state
incorrect
interpret
molecular
test
result
fals
posit
repres
true
posit
result
confirm
either
test
sequenc
pcr
product
present
studi
limit
case
anim
posit
three
test
gpcr
qpcr
qrtpcr
cultur
bvdv
bocv
numer
exampl
case
score
posit
posit
one
two
three
test
thu
select
test
avail
may
depend
question
ask
detect
evid
infect
viral
nucleic
acid
recoveri
infecti
viru
import
real
timepcr
test
especi
multiplex
offer
rapid
test
ct
valu
calcul
negativeposit
test
result
gel
base
pcr
reli
subject
visual
gel
posit
statu
studi
qpcr
qrtpcr
detect
viral
posit
gpcr
cultur
howev
multipl
instanc
gpcr
real
timepcr
neg
case
cultur
posit
bvdv
bocv
therefor
genom
test
alon
may
detect
virus
cell
cultur
use
genet
test
gpcr
qpcr
qrtpcr
rtpcr
result
posit
cultur
posit
qualit
natur
specifi
strain
field
vaccin
strain
potenti
may
multipl
field
strain
respiratori
tract
virus
vaccin
strain
viru
genom
test
gpcr
qpcr
qtrpcr
differenti
field
strain
vaccinederiv
strain
born
genom
assay
studi
detect
field
vaccin
strain
bvdv
multipl
strain
type
subgenotyp
respiratori
tract
virus
hold
true
field
vaccin
strain
bvdv
subgenotyp
compar
respect
vaccin
subgenotyp
ident
studi
find
subgenotyp
alon
specifi
vaccin
strain
strain
vaccin
origin
bvdv
field
vaccin
strain
found
studi
cultur
posit
includ
mlv
vaccin
strain
field
strain
similarli
cultur
isol
analyz
sequenc
inform
permit
assign
strain
specif
vaccin
group
field
strain
statu
mlv
vaccin
strain
field
strain
observ
type
potenti
vaccin
statu
isol
compar
b
c
consid
field
strain
strain
thu
studi
vaccin
field
strain
bvdv
detect
posit
cultur
sampl
analyz
genet
sequenc
primer
use
studi
virus
test
permit
separ
posit
virus
vaccin
field
strain
statu
recoveri
mlv
vaccin
strain
cattl
either
ant
mortem
test
respiratori
tract
sampl
peripher
blood
necropsi
specimen
unexpect
mlv
strain
may
replic
host
replic
virus
potenti
spread
within
host
evidenc
bvdv
certain
vaccin
cross
placenta
result
fetal
infect
prior
studi
report
sever
differ
mlv
vaccin
strain
respiratori
tract
sampl
brd
case
bvdv
vaccin
strain
cultur
lung
cattl
die
feedlot
speci
effect
vaccin
viral
detect
vari
review
cite
prior
author
report
specif
studi
conduct
determin
mlv
vaccin
strain
detect
nasopharyng
nasal
swab
follow
vaccin
howev
refer
cite
mlv
vaccin
strain
identifi
abort
fetus
exhaust
studi
take
sampl
day
vaccin
parenter
administ
mlv
vaccin
one
studi
administ
mlv
vaccin
contain
seroneg
calv
unvaccin
control
calv
separ
pen
includ
along
pregnant
cow
hous
vaccin
nasal
swab
peripher
blood
collect
day
nasal
swab
blood
test
use
viru
cultur
bovin
monolay
gelbas
pcr
test
serum
vaccin
control
test
viral
antibodi
nasal
swab
neg
bvdv
collect
buffi
coat
sampl
vaccin
neg
except
vaccin
bvdv
posit
day
collect
neg
blood
sampl
neg
nasal
swab
collect
neg
gelbas
pcr
bvdv
pcr
posit
blood
sampl
vaccin
bvdv
day
vaccin
control
calv
contact
neg
viru
isol
pcr
collect
control
calv
contact
vaccin
remain
seroneg
though
studi
transient
viremia
cell
cultur
posit
blood
posit
pcr
occur
vaccin
evid
viral
shed
viru
found
mlv
vaccin
detect
mlv
strain
calv
nasal
secret
receiv
parenter
vaccin
label
rout
mean
calv
capabl
infect
anim
nasal
swab
recov
infecti
virus
use
qualit
test
quantit
viru
amount
like
quantit
threshold
viru
requir
nasal
secret
infect
anim
lack
recoveri
brsv
via
cell
cultur
isol
unexpect
studi
use
elisa
pcr
test
viru
isol
cell
cultur
perform
sampl
experiment
infect
brsv
pcr
test
lesser
extent
elisa
may
detect
viru
shed
longer
period
infect
viru
isol
simul
environment
condit
like
experienc
transport
clinic
field
specimen
markedli
reduc
sensit
viru
isol
minim
effect
result
elisa
actual
field
transport
condit
overnight
ice
minim
appar
effect
result
pcr
assay
studi
identifi
virus
cattl
pull
brd
treatment
shortli
arriv
feedlot
cattl
receiv
mlv
viral
vaccin
process
necropsi
case
vari
brd
nasal
swab
tissu
homogen
test
gelbas
pcr
gpcr
real
time
pcr
qpcr
qrtpcr
cell
cultur
recoveri
virus
nasal
swab
cattl
necropsi
case
common
nasal
swab
posit
viru
least
one
three
test
necropsi
case
posit
least
one
viru
recoveri
rate
viru
nasal
swab
indic
five
virus
associ
brd
common
shortli
arriv
rtpcr
test
detect
posit
case
nasal
swab
gpcr
cultur
howev
one
studi
extrem
larg
number
bocv
qrtpcr
posit
compar
test
numer
case
posit
one
two
test
neg
case
genom
test
detect
bvdv
bocv
cultur
posit
field
vaccin
strain
bvdv
recov
cultur
pcr
test
differenti
field
strain
vaccin
strain
bvdv
addit
test
includ
genom
sequencingphylogenet
analysi
use
specif
primer
sequenc
delin
vaccin
field
strain
need
